Cancer News
OncoLink Cancer News - HealthDay


Metformin Use Doesn't Cut Incidence of Bladder Cancer

Tuesday, February 11, 2014 (Last Updated: 02/12/2014)

TUESDAY, Feb. 11, 2014 (HealthDay News) -- For patients with type 2 diabetes, metformin use is not associated with a significantly reduced risk of bladder cancer, according to a study published online Feb. 4 in Diabetes Care.

Ronac Mamtani, M.D., from the University of Pennsylvania in Philadelphia, and colleagues conducted a cohort study involving 87,600 patients with type 2 diabetes in The Health Improvement Network database. The incidence of bladder cancer in new users of metformin and sulfonylureas was examined. Metformin or sulfonylurea use was treated as a time-dependent variable. The authors hoped to address the time-related biases that may have affected previous studies relating to the effect of metformin on cancer risk.

The researchers identified 196 incident bladder cancers in the metformin cohort and 66 in the sulfonylurea cohort. The risk of bladder cancer was not significantly decreased in association with metformin use (hazard ratio, 0.81; 95 percent confidence interval [CI], 0.60 to 1.09). The correlation was not affected by sex (P for interaction = 0.20). There was also no reduction in bladder cancer risk with increased duration of metformin use relative to use of sulfonylureas (three to less than four years of use: 0.57 [95 percent CI, 0.25 to 1.34]; four to less than five years of use: 0.93 [95 percent CI, 0.30 to 2.85]; and five or more years of use: 1.18 [95 percent CI, 0.44 to 3.19]; P for trend = 0.26).

"Similar methods should be used to study other cancers that have previously been identified as potentially preventable with metformin," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Specialties Diabetes & Endocrinology
Hematology & Oncology
Pharmacy
Family Practice
Internal Medicine
Urology

Copyright © 2014 HealthDay. All rights reserved.


I Wish You Knew

HPV is now one of the main risk factors for head & neck cancers

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More